25.01.2022
Introducing our latest publication on SARS-CoV-2 RNA reference material. A significant contribution for all medical laboratories to standardize SARS-CoV-2 RNA diagnostics.
Read more
10.01.2022
On December 16, 2021, the European Parliament adopted a differentiated deferral of the application of individual components of the IVDR. This also partly affects in-vitro-diagnostics from in-house production.
21.12.2021
The quantitative reference samples for virus genome detection of SARS-CoV-2 can be ordered again to be shipped on the 26th January, 2022 (group 7340).
17.12.2021
INSTAND EQA Scheme 416 - Virus Immunology Anti-SARS-CoV-2 - March 2022 extended by 2 additional control samples for an international study by EQALM
04.10.2021
We are pleased to present our new 2022 EQA scheme program.
01.09.2021
You can register now for the following 2021 EQA schemes. The registration deadline is between September 3 and 24, 2021, depending on the EQA scheme.
23.08.2021
Prof. Dr. rer. nat. Ingo Schellenberg, Vice President of the Board at INSTAND, introduces INSTAND at Medlab 2021.
29.07.2021
The overall overviews and associated reports for all EQA schemes can now be accessed in RV-Online.
10.06.2021
With the redesign of the INSTAND website, we took the opportunity to restructure the EQA service area. Learn more here!
31.03.2021
In July 2021, INSTAND launches a new EQA scheme for the determination of Glucose-6 phosphate-dehydrogenase (279). This EQA scheme will be offered twice a year from now on.
Page 1 of 2.
